Active, not recruiting |
: Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
: - Leukemia, Lymphoid
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
: 2010-04-26
: Drug: Lenalidomide plus dexamethasone Lenalidomide 25 mg p.o. once daily on days 1-21 plus Dexamethasone
|
Terminated |
: Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
: - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Acute Lymphobl
: 2009-05-15
: Drug: Nilotinib 400mg, Oral, Bid, Daily for three years
|
Active, not recruiting |
: A Safety Study of SGN-CD19A for Leukemia and Lymphoma
: - Burkitt Lymphoma
- Precursor B-cell Lymphoblastic Leukemia-Lymphoma
: 2013-02-05
: Drug: SGN-CD19A SGN-CD19A (IV) once (Day 1) or twice (Days 1 and 8) every 21 days; dose range: 0.3-6 mg/
|
Terminated |
: A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
: - Acute Lymphoblastic Leukemia
- Precursor B-Cell Lymphoblastic Leukemia
: 2011-11-29
: - Drug: Decitabine 10 mg/m2/day
|
Completed |
: Coproporphyrine Isomers and Methotrexate Elimination
: - Central Nervous System Neoplasms
- Lymphoma, Large B-Cell, Diffuse
-
- Burkitt Lymphoma
- Lymphoma, Follicular
- Lymphoma, Large B-Ce
: 2013-02-05
: Drug: SGN-CD19A SGN-CD19A (IV) once every 21 days (3 weeks) or 42 days (6 weeks)
|
Terminated |
: Acute Lymphoblastic Leukemia Registry at Asan Medical Center
: - Leukemia, Acute Lymphoblastic
- Precursor B-Cell Lymphoblastic Leukemia<
: 2013-01-03
: Other: Diagnosed as ALL All patients who will be enrolled in this prospective registry are confined to t
|
Completed |
: Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)
: - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia, Myel
: 2009-03-17
: - Biological: Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
|
Completed |
: Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)
: - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia, Myel
: 2009-02-20
: - Biological: Haploidentical Bone Marrow Transplantation
|